Advertisement
Advertisement
U.S. Markets close in 2 hrs 54 mins
Advertisement
Advertisement
Advertisement
Advertisement

Zydus Lifesciences Limited (ZYDUSLIFE.NS)

NSE - NSE Real Time Price. Currency in INR
415.50+4.35 (+1.06%)
At close: 03:30PM IST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in INR

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 12/2/2022
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.54
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 3486.85
52 Week Low 3319.00
50-Day Moving Average 3411.88
200-Day Moving Average 3373.86

Share Statistics

Avg Vol (3 month) 31.41M
Avg Vol (10 day) 3932.04k
Shares Outstanding 5N/A
Implied Shares Outstanding 6N/A
Float 8253.63M
% Held by Insiders 175.39%
% Held by Institutions 113.10%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 42.5
Forward Annual Dividend Yield 40.60%
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 416.50%
Dividend Date 3N/A
Ex-Dividend Date 4Jul 28, 2022
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2022
Most Recent Quarter (mrq)Jun 30, 2022

Profitability

Profit Margin 28.81%
Operating Margin (ttm)16.19%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)153.36B
Revenue Per Share (ttm)149.76
Quarterly Revenue Growth (yoy)1.20%
Gross Profit (ttm)95.8B
EBITDA 31.82B
Net Income Avi to Common (ttm)21.71B
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)-11.70%

Balance Sheet

Total Cash (mrq)39.74B
Total Cash Per Share (mrq)38.81
Total Debt (mrq)42.21B
Total Debt/Equity (mrq)22.15
Current Ratio (mrq)N/A
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A
Advertisement
Advertisement